Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
61
BKSY Quote, Financials, Valuation and Earnings
Last price:
$28.29
Seasonality move
:
-22.88%
Day range:
$24.51 - $26.41
52-week range:
$3.86 - $26.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.96x
P/B ratio:
9.17x
Volume:
1.5M
Avg. volume:
2M
1-year change:
175.11%
Market cap:
$814.3M
Revenue:
$102.1M
EPS (TTM):
-$2.57
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.1M | $34.1M | $65.4M | $94.5M | $102.1M | |
| Revenue Growth (YoY) | -- | 61.27% | 91.73% | 44.59% | 8.04% | |
| Cost of Revenues | $23.9M | $34.7M | $35.8M | $33.8M | $27.4M | |
| Gross Profit | -$2.7M | -$663K | $29.5M | $60.7M | $74.7M | |
| Gross Profit Margin | -12.92% | -1.95% | 45.18% | 64.25% | 73.13% | |
| R&D Expenses | $7.4M | $1.5M | $1.6M | $1.7M | $2.3M | |
| Selling, General & Admin | $21.4M | $85.2M | $78.8M | $71.6M | $73.1M | |
| Other Inc / (Exp) | -$1.1M | -$89.4M | $16M | $11.8M | -$1.9M | |
| Operating Expenses | $38.7M | $101.1M | $116.1M | $116.7M | $118.9M | |
| Operating Income | -$41.4M | -$101.7M | -$86.5M | -$56M | -$44.3M | |
| Net Interest Expenses | $5.2M | $52.9M | $4.3M | $9M | $10.6M | |
| EBT. Incl. Unusual Items | -$47.7M | -$244M | -$74.9M | -$53.2M | -$56.8M | |
| Earnings of Discontinued Ops. | $28.2M | -$1.7M | $707K | -- | -- | |
| Income Tax Expense | -- | -- | -- | $673K | $370K | |
| Net Income to Company | -$47.7M | -$244M | -$74.9M | -$53.9M | -$57.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$19.5M | -$245.6M | -$74.2M | -$53.9M | -$57.2M | |
| Basic EPS (Cont. Ops) | -$1.35 | -$27.12 | -$5.04 | -$3.18 | -$2.67 | |
| Diluted EPS (Cont. Ops) | -$1.35 | -$27.12 | -$5.04 | -$3.18 | -$2.67 | |
| Weighted Average Basic Share | $14.5M | $14.3M | $14.7M | $16.9M | $21.4M | |
| Weighted Average Diluted Share | $14.5M | $14.3M | $14.7M | $16.9M | $21.4M | |
| EBITDA | -$32.7M | -$224.5M | -$32.1M | $434K | -$542K | |
| EBIT | -$42.5M | -$238.8M | -$69.5M | -$43.9M | -$44.7M | |
| Revenue (Reported) | $21.1M | $34.1M | $65.4M | $94.5M | $102.1M | |
| Operating Income (Reported) | -$41.4M | -$101.7M | -$86.5M | -$56M | -$44.3M | |
| Operating Income (Adjusted) | -$42.5M | -$238.8M | -$69.5M | -$43.9M | -$44.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3M | $13.9M | $18.4M | $24.2M | $29.5M | |
| Revenue Growth (YoY) | -- | 90.51% | 32.39% | 31.74% | 21.9% | |
| Cost of Revenues | $5.5M | $11M | $6.5M | $7M | $12.6M | |
| Gross Profit | $1.8M | $2.9M | $11.9M | $17.2M | $16.9M | |
| Gross Profit Margin | 24.47% | 21.16% | 64.79% | 70.98% | 57.35% | |
| R&D Expenses | $28K | $318K | $563K | $725K | $589K | |
| Selling, General & Admin | $8.5M | $22.4M | $18.6M | $18.5M | $21.1M | |
| Other Inc / (Exp) | -$110.3M | $8.4M | $2M | -$253K | $2M | |
| Operating Expenses | $11.3M | $30.1M | $28.8M | $30.5M | $28.9M | |
| Operating Income | -$9.5M | -$27.1M | -$16.9M | -$13.3M | -$12M | |
| Net Interest Expenses | $48.8M | $1.3M | $2.3M | $2.2M | $2.8M | |
| EBT. Incl. Unusual Items | -$168.6M | -$20M | -$17.2M | -$15.7M | -$12.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $113K | $70K | $30K | |
| Net Income to Company | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Basic EPS (Cont. Ops) | -$11.63 | -$1.36 | -$1.12 | -$0.88 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -$11.63 | -$1.36 | -$1.12 | -$0.88 | -$0.42 | |
| Weighted Average Basic Share | $14.5M | $14.4M | $15.5M | $17.9M | $30.8M | |
| Weighted Average Diluted Share | $14.5M | $14.4M | $15.5M | $17.9M | $30.8M | |
| EBITDA | -$164.6M | -$11M | -$5.2M | -$1.7M | -$2M | |
| EBIT | -$167.4M | -$18.7M | -$15.3M | -$13.1M | -$9.4M | |
| Revenue (Reported) | $7.3M | $13.9M | $18.4M | $24.2M | $29.5M | |
| Operating Income (Reported) | -$9.5M | -$27.1M | -$16.9M | -$13.3M | -$12M | |
| Operating Income (Adjusted) | -$167.4M | -$18.7M | -$15.3M | -$13.1M | -$9.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $40.7M | $69.9M | $100.3M | $107.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $40.2M | $31.4M | $34.3M | $33M | |
| Gross Profit | -- | $493K | $38.5M | $66M | $74.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $1.7M | $1.8M | $1.8M | $2.2M | |
| Selling, General & Admin | -- | $99.3M | $75.1M | $71.5M | $75.7M | |
| Other Inc / (Exp) | -$111.1M | $29.3M | $9.6M | $9.5M | $286K | |
| Operating Expenses | -- | $119.9M | $114.8M | $118.3M | $117.4M | |
| Operating Income | -- | -$119.4M | -$76.3M | -$52.3M | -$43M | |
| Net Interest Expenses | $50.7M | $5.3M | $5.4M | $8.9M | $11.2M | |
| EBT. Incl. Unusual Items | -- | -$95.4M | -$72.1M | -$51.7M | -$53.9M | |
| Earnings of Discontinued Ops. | -$775K | -$1.7M | $707K | -- | -- | |
| Income Tax Expense | -- | -- | $113K | $630K | $330K | |
| Net Income to Company | -- | -$95.4M | -$72.2M | -$52.4M | -$54.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$97.1M | -$71.5M | -$52.4M | -$54.2M | |
| Basic EPS (Cont. Ops) | -- | -$8.80 | -$4.80 | -$3.00 | -$2.57 | |
| Diluted EPS (Cont. Ops) | -- | -$8.80 | -$4.80 | -$3.00 | -$2.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -$70.9M | -$26.4M | $4M | -$859K | |
| EBIT | -- | -$90.2M | -$66.1M | -$41.6M | -$41M | |
| Revenue (Reported) | -- | $40.7M | $69.9M | $100.3M | $107.4M | |
| Operating Income (Reported) | -- | -$119.4M | -$76.3M | -$52.3M | -$43M | |
| Operating Income (Adjusted) | -- | -$90.2M | -$66.1M | -$41.6M | -$41M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3M | $13.9M | $18.4M | $24.2M | $29.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.5M | $11M | $6.5M | $7M | $12.6M | |
| Gross Profit | $1.8M | $2.9M | $11.9M | $17.2M | $16.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $28K | $318K | $563K | $725K | $589K | |
| Selling, General & Admin | $8.5M | $22.4M | $18.6M | $18.5M | $21.1M | |
| Other Inc / (Exp) | -$110.3M | $8.4M | $2M | -$253K | $2M | |
| Operating Expenses | $11.3M | $30.1M | $28.8M | $30.5M | $28.9M | |
| Operating Income | -$9.5M | -$27.1M | -$16.9M | -$13.3M | -$12M | |
| Net Interest Expenses | $48.8M | $1.3M | $2.3M | $2.2M | $2.8M | |
| EBT. Incl. Unusual Items | -$168.6M | -$20M | -$17.2M | -$15.7M | -$12.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $113K | $70K | $30K | |
| Net Income to Company | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Basic EPS (Cont. Ops) | -$11.63 | -$1.36 | -$1.12 | -$0.88 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -$11.63 | -$1.36 | -$1.12 | -$0.88 | -$0.42 | |
| Weighted Average Basic Share | $14.5M | $14.4M | $15.5M | $17.9M | $30.8M | |
| Weighted Average Diluted Share | $14.5M | $14.4M | $15.5M | $17.9M | $30.8M | |
| EBITDA | -$164.6M | -$11M | -$5.2M | -$1.7M | -$2M | |
| EBIT | -$167.4M | -$18.7M | -$15.3M | -$13.1M | -$9.4M | |
| Revenue (Reported) | $7.3M | $13.9M | $18.4M | $24.2M | $29.5M | |
| Operating Income (Reported) | -$9.5M | -$27.1M | -$16.9M | -$13.3M | -$12M | |
| Operating Income (Adjusted) | -$167.4M | -$18.7M | -$15.3M | -$13.1M | -$9.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.1M | $165.6M | $34.2M | $32.8M | $13.1M | |
| Short Term Investments | -- | -- | $38M | $19.7M | $39.4M | |
| Accounts Receivable, Net | $2.9M | $2.6M | $3.1M | $7.1M | $14.7M | |
| Inventory | -- | -- | -- | -- | $6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $965K | $6.3M | $4.7M | $3.9M | $4.4M | |
| Total Current Assets | $18.2M | $178.7M | $88.5M | $79.3M | $106.7M | |
| Property Plant And Equipment | $83.5M | $110.7M | $126.1M | $124.7M | $130.2M | |
| Long-Term Investments | $3.3M | $4M | $5.3M | -- | -- | |
| Goodwill | $9.4M | $9.4M | $9.4M | $9.4M | $10.3M | |
| Other Intangibles | $3.8M | $2.5M | $1.9M | $1.4M | $5.4M | |
| Other Long-Term Assets | $1.7M | $560K | $2.8M | $9.3M | $1.5M | |
| Total Assets | $119.9M | $305.8M | $234.1M | $224.1M | $254.1M | |
| Accounts Payable | $4.2M | $1.7M | $2.4M | $2.3M | $8.2M | |
| Accrued Expenses | $3.8M | $9.1M | $13.1M | $9.6M | $12.6M | |
| Current Portion Of Long-Term Debt | $16.7M | -- | -- | -- | $1.9M | |
| Current Portion Of Capital Lease Obligations | $48K | $49K | $530K | $621K | $775K | |
| Other Current Liabilities | $7.4M | $2.8M | $256K | $244K | $182K | |
| Total Current Liabilities | $55.4M | $30.5M | $26.9M | $27.5M | $26M | |
| Long-Term Debt | $84.9M | $71.4M | $76.2M | $83.5M | $105.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $152.7M | $126.1M | $112.2M | $130.9M | $160.2M | |
| Common Stock | $3K | $11K | $12K | $2K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$32.8M | $179.6M | $121.9M | $93.2M | $94M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$32.8M | $179.6M | $121.9M | $93.2M | $94M | |
| Total Liabilities and Equity | $119.9M | $305.8M | $234.1M | $224.1M | $254.1M | |
| Cash and Short Terms | $5.1M | $165.6M | $72.2M | $52.5M | $52.5M | |
| Total Debt | $101.6M | $71.4M | $76.2M | $83.5M | $107.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $135.9M | $57M | $15M | $20.7M | |
| Short Term Investments | -- | -- | $11.8M | $20.4M | $55.1M | |
| Accounts Receivable, Net | -- | $5.5M | $9.1M | $5.6M | $7.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $5M | $4.3M | $3.8M | $4M | |
| Total Current Assets | -- | $151.8M | $91.4M | $69.4M | $121.3M | |
| Property Plant And Equipment | -- | $118.9M | $130.3M | $126.5M | $140.1M | |
| Long-Term Investments | -- | $4.3M | $5.8M | -- | -- | |
| Goodwill | -- | $9.4M | $9.4M | $9.4M | $10.3M | |
| Other Intangibles | -- | $2.3M | $1.8M | $1.2M | $5.2M | |
| Other Long-Term Assets | -- | $565K | $2.6M | $3.6M | $7.9M | |
| Total Assets | -- | $287.3M | $241.2M | $210.1M | $284.9M | |
| Accounts Payable | -- | $15.5M | $10.6M | $13.1M | $13M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $2.6M | $4M | $1.6M | $2.6M | |
| Total Current Liabilities | -- | $31.6M | $20.9M | $17.3M | $32M | |
| Long-Term Debt | -- | $71.9M | $76.3M | $84.7M | $111.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $120.4M | $122.3M | $128.4M | $196M | |
| Common Stock | -- | $12K | $14K | $14K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $166.9M | $118.9M | $81.7M | $88.8M | |
| Total Liabilities and Equity | -- | $287.3M | $241.2M | $210.1M | $284.9M | |
| Cash and Short Terms | -- | $135.9M | $68.8M | $35.4M | $75.8M | |
| Total Debt | -- | $71.9M | $76.3M | $85M | $115.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$47.7M | -$244M | -$74.9M | -$53.9M | -$57.2M | |
| Depreciation & Amoritzation | $9.8M | $14.3M | $37.3M | $44.3M | $44.1M | |
| Stock-Based Compensation | $2M | $42.6M | $20M | $10.9M | $11.2M | |
| Change in Accounts Receivable | -$2.4M | $2.3M | -$6.5M | -$20.4M | -$12.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$31.7M | -$53.9M | -$44.5M | -$17.4M | -$6.4M | |
| Capital Expenditures | $281K | $1.3M | $11.7M | $15.3M | $15.7M | |
| Cash Acquisitions | -- | $302K | $804K | $9.5M | $541K | |
| Cash From Investing | -$9.8M | -$63.6M | -$81.6M | -$15.2M | -$68.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.6M | $58.6M | -- | -- | $20M | |
| Long-Term Debt Repaid | -$39K | -$22.2M | -- | -- | -$10M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$147K | -$6.5M | -$5.1M | -$3.7M | -$1.7M | |
| Cash From Financing | $3.4M | $275M | -$5.1M | $29.1M | $55.7M | |
| Beginning Cash (CF) | $37.2M | $10.6M | $168.1M | $37M | $33.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38M | $157.5M | -$131.1M | -$3.6M | -$19.1M | |
| Ending Cash (CF) | $10.6M | $168.1M | $37M | $33.4M | $14.4M | |
| Levered Free Cash Flow | -$32M | -$55.1M | -$56.1M | -$32.7M | -$22.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Depreciation & Amoritzation | $2.8M | $7.8M | $10.1M | $11.4M | $7.4M | |
| Stock-Based Compensation | $508K | $10.2M | $3M | $3.4M | $2.9M | |
| Change in Accounts Receivable | -$1.7M | -$4.1M | -$6.5M | -$1.9M | -$4.3M | |
| Change in Inventories | -- | -- | -- | -- | $6M | |
| Cash From Operations | -$10.6M | -$12.7M | -$16.6M | -$3.8M | $27.2M | |
| Capital Expenditures | $17K | $1.9M | $2.9M | $3.3M | $4.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.5M | -$13.4M | $10.5M | -$15.1M | -$24.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $58.1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$412K | -$3.6M | -$568K | -$437K | -$698K | |
| Cash From Financing | $57.8M | -$3.6M | $28.9M | $862K | $4.4M | |
| Beginning Cash (CF) | $10.6M | $168.1M | $37M | $33.4M | $14.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $39.7M | -$29.7M | $22.8M | -$18.1M | $7.5M | |
| Ending Cash (CF) | $50.3M | $138.4M | $59.8M | $15.4M | $21.9M | |
| Levered Free Cash Flow | -$10.6M | -$14.6M | -$19.5M | -$7.1M | $22.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$95.4M | -$72.2M | -$52.4M | -$54.2M | |
| Depreciation & Amoritzation | -- | $19.3M | $39.7M | $45.6M | $40.1M | |
| Stock-Based Compensation | $508K | $52.3M | $12.8M | $11.2M | $10.7M | |
| Change in Accounts Receivable | -- | -$4K | -$8.9M | -$15.8M | -$15.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$56M | -$48.4M | -$4.6M | $24.7M | |
| Capital Expenditures | $17K | $3.2M | $12.6M | $15.7M | $16.8M | |
| Cash Acquisitions | -- | $302K | $804K | -- | -- | |
| Cash From Investing | -- | -$69.5M | -$57.6M | -$40.8M | -$77.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$9.7M | -$2.1M | -$3.6M | -$1.9M | |
| Cash From Financing | -- | $213.6M | $27.4M | $1M | $59.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $88.1M | -$78.6M | -$44.4M | $6.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$59.1M | -$61M | -$20.3M | $7.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$168.6M | -$20M | -$17.3M | -$15.8M | -$12.8M | |
| Depreciation & Amoritzation | $2.8M | $7.8M | $10.1M | $11.4M | $7.4M | |
| Stock-Based Compensation | $508K | $10.2M | $3M | $3.4M | $2.9M | |
| Change in Accounts Receivable | -$1.7M | -$4.1M | -$6.5M | -$1.9M | -$4.3M | |
| Change in Inventories | -- | -- | -- | -- | $6M | |
| Cash From Operations | -$10.6M | -$12.7M | -$16.6M | -$3.8M | $27.2M | |
| Capital Expenditures | $17K | $1.9M | $2.9M | $3.3M | $4.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.5M | -$13.4M | $10.5M | -$15.1M | -$24.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $58.1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$412K | -$3.6M | -$568K | -$437K | -$698K | |
| Cash From Financing | $57.8M | -$3.6M | $28.9M | $862K | $4.4M | |
| Beginning Cash (CF) | $10.6M | $168.1M | $37M | $33.4M | $14.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $39.7M | -$29.7M | $22.8M | -$18.1M | $7.5M | |
| Ending Cash (CF) | $50.3M | $138.4M | $59.8M | $15.4M | $21.9M | |
| Levered Free Cash Flow | -$10.6M | -$14.6M | -$19.5M | -$7.1M | $22.8M | |
Get BKSY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BKSY
Sector
P/E ratio
--
18.58x
PEG ratio
--
0.25x
P/B ratio
9.17x
1.75x
Price / LTM sales
5.96x
0.94x
Growth Metrics
BKSY
Sector
Revenue growth
21.9%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
-$0.41
$0.40
Profitability
BKSY
Sector
Profitability FY 2024
$74.7M
$393.9M
Return on invested capital
-28.05%
5.32%
Return on assets
-22.24%
3.49%
Return on equity
-60.07%
8.55%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
BKSY
Sector
Total cash
$75.8M
$154.3M
Short term investments
$39.4M
$35.5M
Total assets
$254.1M
$1.7B
Long term debt
$115.3M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
